Tīmeklis2024. gada 8. sept. · IgA nephropathy (IgAN) is the most common type of glomerulonephritis in Asia and the Western world. In most patients, it follows an asymptomatic to oligosymptomatic course and GFR loss, if any, is slow. The mainstay of therapy therefore is optimized supportive care, i.e., measures that lower blood … TīmeklisNational Center for Biotechnology Information
Clinical Trials Register
Tīmeklis2024. gada 1. sept. · IgA nephropathy (IgAN) is common and often progresses to end stage renal disease. IgAN encompasses a wide range of histology and clinical … Tīmeklis2024. gada 9. marts · Immunoglobulin A nephropathy (IgAN), characterized by glomerular IgA deposits on renal biopsy, is one of the most common primary … birch lane end tables with storage
Ravulizumab - Alexion AstraZeneca Rare Disease - AdisInsight
Tīmeklis2024. gada 17. apr. · Immunoglobulin A (IgA) nephropathy is a common form of glomerulonephritis, which despite use of renin-angiotensin-aldosterone-system blockers and immunosuppressants, often progresses to kidney failure. In the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease trial, … TīmeklisIn this open label, multicenter study conducted over 1-year follow-up, we randomized 34 adult patients with biopsy-proven IgA nephropathy and proteinuria >1 g/d, maintained on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with well controlled BP and eGFR<90 ml/min per 1.73 m 2, to receive standard therapy or ... Tīmeklis2024. gada 8. dec. · Iptacopan is also being investigated in Phase III studies for the complement-mediated kidney diseases (CMKDs) C3 glomerulopathy (APPEAR-C3G [NCT04817618]), IgA nephropathy (APPLAUSE-IgAN [NCT04578834]), and atypical hemolytic uremic syndrome (APPELHUS [NCT04889430]), as well as in a number of … birch lane decorative pillows